Venous Thromboembolism Treatment Market - Global Industry Analysis, Size, Share, Growth Trends, and Forecasts 2018 - 2028

  • Single User License $3500

Venous Thromboembolism Treatment Market - Global Industry Analysis, Size, Share, Growth Trends, and Forecasts 2018 - 2028

Status : September, 2020 | Medical Devices | PPT format

Report Digest

Global Venous Thromboembolism Treatment Market: Overview 

When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts.  A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing this in the U.S. every year. Moreover, large number of patients are at high risk due to higher levels of venous thromboembolism. In these situations, retrievable vena cava filters aids in preventing the progression of deadly pulmonary embolism through bedside prophylactic treatment. 

As the occurrence of this condition is increasing significantly, market research firm are coming analyzing the opportunities to get clear knowledge about the treatment provided for venous thromboembolism. In the global venous thromboembolism treatment market report, all the key factors driving growth in the market are discussed that helps in giving complete picture of the market. Key drivers, restraints, opportunity, and challenges along with in-depth analysis of competitive landscape and geographical growth in the global lip fillers market are all thoroughly discussed in the report. SWOT and PESTEL analysis is also presented in the report. 

Global Venous Thromboembolism Treatment Market: Notable Developments

Recent developments taking place in the healthcare sector that to especially in condition related to cardiology are considered to be the driving factors influencing growth in the global venous thromboembolism treatment market. Players engaged in this are the key influencers. Leading players in the global venous thromboembolism treatment market are involved in innovating and developing new products that are highly efficient. Moreover, prominent players are also investing in establishing partnership and collaboration with catheterisation laboratories, hospitals, and ambulatory surgical centers. These initiatives will help the players in getting a strong hold in the market and increase share holdings against their competitors. 

Some of the leading vendors in the global venous thromboembolism treatment market are: 

  • ArjoHuntleigh AB
  • BTG International Ltd.
  • AngioDynamics
  • Cardinal Health Inc.
  • Stryker Corporation
  • EKOS Corp
  • DJO Global Inc.
  • Boston Scientific Corp.
  • Teleflex Inc.

Global Venous Thromboembolism Treatment Market: Drivers 

One of the key driver augmenting growth in the global venous thromboembolism treatment market is the novel development of oral anticoagulants (NOACs) that helps in overcoming the limitation of current available treatment options and helps in providing improved care to the patients. Currently available treatments in this market include blood-thinning agents that include anticoagulants (low molecular and unfractionated weight heparin as well as warfarin), thrombolytic therapy (tissue plasminogen activator), and mechanical devices (compression stockings). 

Global Venous Thromboembolism Treatment Market: Geographical Analysis 

Regionally, North America is expected to lead the global venous thromboembolism treatment market. Presence of leading players along well-developed healthcare infrastructure in the region made the North America a leading market. Moreover, significant rise in technological advancements in the region has further segmented growth of North America venous thromboembolism treatment market. Europe on the other hand is also expected to hold substantial share in the global venous thromboembolism treatment market in the coming years due to the rise in drug-based treatment that gained popularity in this region. 

The global venous thromboembolism treatment market has been segmented as below:           

Product Type

  • Catheter-Directed Thrombolysis (CDT) Devices
  • Percutaneous Thrombectomy Devices
  • Segmented Pneumatic Compression Pumps without Gradient

Disease Indication

  • Deep Venous Thrombosis
  • Pulmonary Embolism

Disease Indication

  • Hospitals
  • Catheterisation Laboratories
  • Ambulatory Surgical Centers

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.